John Wharton

15.7k total citations
187 papers, 9.0k citations indexed

About

John Wharton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, John Wharton has authored 187 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 73 papers in Molecular Biology and 67 papers in Cellular and Molecular Neuroscience. Recurrent topics in John Wharton's work include Neuropeptides and Animal Physiology (67 papers), Pulmonary Hypertension Research and Treatments (67 papers) and Receptor Mechanisms and Signaling (43 papers). John Wharton is often cited by papers focused on Neuropeptides and Animal Physiology (67 papers), Pulmonary Hypertension Research and Treatments (67 papers) and Receptor Mechanisms and Signaling (43 papers). John Wharton collaborates with scholars based in United Kingdom, United States and Portugal. John Wharton's co-authors include J. M. Polak, Martin R. Wilkins, S. Gulbenkian, Julia M. Polak, Stephen R. Bloom, Christopher J. Rhodes, Luke Howard, J.M. Polak, A. G. E. Pearse and Magdi H. Yacoub and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

John Wharton

186 papers receiving 8.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wharton United Kingdom 54 3.2k 3.0k 2.6k 2.4k 1.7k 187 9.0k
Anders Franco‐Cereceda Sweden 44 1.5k 0.5× 2.4k 0.8× 2.1k 0.8× 2.7k 1.1× 1.3k 0.8× 219 6.9k
Adel Giaid Canada 47 3.8k 1.2× 2.3k 0.8× 3.4k 1.3× 697 0.3× 4.1k 2.4× 115 11.2k
Hiroshi Arai Japan 43 1.3k 0.4× 3.4k 1.1× 3.4k 1.3× 727 0.3× 3.1k 1.8× 227 9.2k
Armin Kurtz Germany 62 1.3k 0.4× 6.1k 2.0× 2.5k 1.0× 871 0.4× 2.1k 1.3× 403 13.2k
D.R. Springall United Kingdom 50 1.7k 0.5× 1.7k 0.6× 957 0.4× 1.9k 0.8× 3.6k 2.1× 142 7.7k
Peter Mündel United States 74 1.1k 0.4× 8.3k 2.7× 1.7k 0.6× 1.1k 0.4× 2.0k 1.2× 158 20.0k
Serge Adnot France 65 8.0k 2.5× 2.9k 1.0× 3.7k 1.4× 420 0.2× 2.8k 1.7× 215 12.4k
Takao Masaki Japan 39 944 0.3× 3.3k 1.1× 2.4k 0.9× 986 0.4× 4.6k 2.7× 240 8.9k
Guido Stoll Germany 69 956 0.3× 3.7k 1.2× 1.3k 0.5× 3.8k 1.5× 1.6k 0.9× 258 15.9k
Hidenori Suzuki Japan 50 1.4k 0.4× 2.9k 1.0× 856 0.3× 1.1k 0.5× 1.1k 0.6× 343 8.6k

Countries citing papers authored by John Wharton

Since Specialization
Citations

This map shows the geographic impact of John Wharton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wharton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wharton more than expected).

Fields of papers citing papers by John Wharton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wharton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wharton. The network helps show where John Wharton may publish in the future.

Co-authorship network of co-authors of John Wharton

This figure shows the co-authorship network connecting the top 25 collaborators of John Wharton. A scholar is included among the top collaborators of John Wharton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wharton. John Wharton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhodes, Christopher J., Lihan Zhou, Eileen M. Harder, et al.. (2025). Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension. Circulation Genomic and Precision Medicine. 18(3). e004862–e004862. 1 indexed citations
2.
Liu, Bin, Ekaterina Legchenko, James A. West, et al.. (2024). ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport. Cardiovascular Research. 120(7). 756–768. 7 indexed citations
3.
Hajji, Nabil, Sunniyat Rahman, John Wharton, et al.. (2023). Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology. American Journal of Respiratory and Critical Care Medicine. 208(8). 879–895. 18 indexed citations
4.
Ainscough, Alexander J., Christopher J. Rhodes, Harry J. Whitwell, et al.. (2022). An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. Communications Biology. 5(1). 1192–1192. 18 indexed citations
5.
Wharton, John, Eleni Vasilaki, Jurjan Aman, et al.. (2021). The pathophysiological role of novel pulmonary arterial hypertension geneSOX17. European Respiratory Journal. 58(3). 2004172–2004172. 16 indexed citations
6.
Harbaum, Lars, et al.. (2020). The application of ‘omics’ to pulmonary arterial hypertension. British Journal of Pharmacology. 178(1). 108–120. 22 indexed citations
7.
Harbaum, Lars, Pavandeep Ghataorhe, John Wharton, et al.. (2018). Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax. 74(4). 380–389. 30 indexed citations
8.
Ashek, Ali, Onno A. Spruijt, Hendrik J. Harms, et al.. (2018). 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung. Circulation Cardiovascular Imaging. 11(8). e007402–e007402. 11 indexed citations
9.
10.
Rhodes, Christopher J., John Wharton, Reinier A. Boon, et al.. (2012). Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 187(3). 294–302. 134 indexed citations
11.
Growcott, Ellena, et al.. (2011). Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells. Respiratory Research. 12(1). 137–137. 22 indexed citations
12.
Zhao, Lin, Abdelkrim Sebkhi, Beata Wójciak‐Stothard, et al.. (2009). Simvastatin and sildenafil combine to attenuate pulmonary hypertension. European Respiratory Journal. 34(4). 948–957. 46 indexed citations
13.
Rhodes, Christopher J., John Wharton, Luke Howard, et al.. (2009). Abstract 5657: Growth Differentiation Factor-15 as a Biomarker in Pulmonary Arterial Hypertension and Hypoxia-induced Pulmonary Hypertension. Circulation. 120(suppl_18). 1 indexed citations
14.
Rhodes, Christopher J., Alexandra Davidson, J. Simon R. Gibbs, John Wharton, & Martin R. Wilkins. (2008). Therapeutic targets in pulmonary arterial hypertension. Pharmacology & Therapeutics. 121(1). 69–88. 65 indexed citations
15.
Wharton, John, Julian Strange, Ellena Growcott, et al.. (2005). Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells. American Journal of Respiratory and Critical Care Medicine. 172(1). 105–113. 279 indexed citations
16.
Davie, Neil, Paul D. Upton, Julia M. Polak, et al.. (2002). ETA and ETB Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells. American Journal of Respiratory and Critical Care Medicine. 165(3). 398–405. 248 indexed citations
17.
Polak, Julia M. & John Wharton. (1993). Receptor autoradiography : principles and practice. Oxford University Press eBooks. 21 indexed citations
18.
Gordon, L, et al.. (1993). Development of the peptidergic innervation of human heart.. PubMed. 183 ( Pt 1). 131–40. 41 indexed citations
19.
Gulbenkian, S., et al.. (1992). Neuropeptide Y modulates the action of vasodilator agents in guinea-pig epicardial coronary arteries. Regulatory Peptides. 40(3). 351–362. 12 indexed citations
20.
Noorden, Susan Van, et al.. (1979). Vasoactive intestinal peptide-like immunoreactivity in salivary glands of the rat [proceedings].. PubMed. 289. 23P–23P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Franco‐Cereceda Breakdown of academic impact, for papers by Adel Giaid Breakdown of academic impact, for papers by Hiroshi Arai Breakdown of academic impact, for papers by Armin Kurtz Breakdown of academic impact, for papers by D.R. Springall Breakdown of academic impact, for papers by Peter Mündel Breakdown of academic impact, for papers by Serge Adnot Breakdown of academic impact, for papers by Takao Masaki Breakdown of academic impact, for papers by Guido Stoll Breakdown of academic impact, for papers by Hidenori Suzuki
Rankless by CCL
2026